• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Role of hospitalization for inflammatory bowel disease in the post-biologic era.生物制剂时代后炎症性肠病住院治疗的作用
World J Clin Cases. 2021 Sep 16;9(26):7632-7642. doi: 10.12998/wjcc.v9.i26.7632.
2
Characterizing Regionalization of Inflammatory Bowel Disease Hospitalizations and Operations in Washington State.描述华盛顿州炎症性肠病住院和手术的区域化特征。
J Gastrointest Surg. 2023 Nov;27(11):2493-2505. doi: 10.1007/s11605-023-05731-8. Epub 2023 Aug 2.
3
Variations in care: a retrospective database analysis of healthcare utilization patterns for patients with inflammatory bowel disease.护理差异:炎症性肠病患者医疗利用模式的回顾性数据库分析
J Med Econ. 2015 Feb;18(2):137-44. doi: 10.3111/13696998.2014.978454. Epub 2014 Oct 30.
4
Biologic therapy is associated with a mild decrease in the rate of hospitalizations in pediatric IBD.生物疗法与儿科 IBD 患者住院率的轻度下降有关。
BMC Pediatr. 2021 Feb 4;21(1):63. doi: 10.1186/s12887-021-02526-1.
5
Predictors for poor outcome of hospitalized children with inflammatory bowel disease.住院儿童炎症性肠病不良结局的预测因素。
Eur J Pediatr. 2020 Jan;179(1):157-164. doi: 10.1007/s00431-019-03491-9. Epub 2019 Nov 11.
6
Quality of Care and Outcomes Among Hospitalized Inflammatory Bowel Disease Patients: A Multicenter Retrospective Study.住院炎症性肠病患者的医疗质量与结局:一项多中心回顾性研究
Inflamm Bowel Dis. 2017 May;23(5):695-701. doi: 10.1097/MIB.0000000000001068.
7
Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014.瑞士炎症性肠病患者的患病率、死亡率、医疗保健利用情况及医疗保健费用趋势:基于2010年、2012年和2014年理赔数据的研究
BMC Gastroenterol. 2017 Dec 2;17(1):138. doi: 10.1186/s12876-017-0681-y.
8
Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based Analysis.生物制剂时代炎症性肠病的直接成本和医疗保健利用的纵向趋势:来自加拿大基于人群的分析结果。
Am J Gastroenterol. 2020 Jan;115(1):128-137. doi: 10.14309/ajg.0000000000000503.
9
Transitions of care across hospital settings in patients with inflammatory bowel disease.炎症性肠病患者在医院环境中的转院治疗。
World J Gastroenterol. 2019 May 7;25(17):2122-2132. doi: 10.3748/wjg.v25.i17.2122.
10
Increased Healthcare Utilization by Patients With Inflammatory Bowel Disease Covered by Medicaid at a Tertiary Care Center.在一家三级护理中心,医疗补助计划覆盖的炎症性肠病患者的医疗保健利用率增加。
Inflamm Bowel Dis. 2019 Sep 18;25(10):1711-1717. doi: 10.1093/ibd/izz060.

引用本文的文献

1
Treat-to-Target in Inflammatory Bowel Disease: An Updated Survey of Treatment Strategies among Portuguese Gastroenterologists.炎症性肠病的达标治疗:葡萄牙胃肠病学家治疗策略的最新调查
GE Port J Gastroenterol. 2024 Nov 5;32(4):273-280. doi: 10.1159/000541867. eCollection 2025 Jul.
2
Global Patterns of Infection in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Prevalence, Epidemiology, and Risk Factors.炎症性肠病患者的全球感染模式:患病率、流行病学和危险因素的系统评价与荟萃分析
Crohns Colitis 360. 2025 Mar 27;7(2):otaf024. doi: 10.1093/crocol/otaf024. eCollection 2025 Apr.
3
Effect of Risankizumab Induction and Maintenance Therapy on the Rate of Hospitalization in Patients with Crohn's Disease.瑞莎珠单抗诱导和维持治疗对克罗恩病患者住院率的影响。
Gastro Hep Adv. 2024 Dec 24;4(4):100603. doi: 10.1016/j.gastha.2024.100603. eCollection 2025.
4
The impact of cognitive functions, psychological disorders, and coping strategies on quality of life and disease outcomes in patients with inflammatory bowel diseases: A cross-sectional study.认知功能、心理障碍和应对策略对炎症性肠病患者生活质量和疾病结局的影响:一项横断面研究。
Medicine (Baltimore). 2024 Jul 26;103(30):e38982. doi: 10.1097/MD.0000000000038982.
5
Contrast-Enhanced Endoscopic Ultrasound Detects Early Therapy Response Following Anti-TNF Therapy in Patients with Ulcerative Colitis.对比增强内镜超声检测溃疡性结肠炎患者接受抗 TNF 治疗后的早期治疗反应。
J Crohns Colitis. 2024 Aug 6;18(7):1012-1024. doi: 10.1093/ecco-jcc/jjae034.

本文引用的文献

1
Day-by-Day Management of the Inpatient With Moderate to Severe Inflammatory Bowel Disease.中重度炎症性肠病住院患者的每日管理
Gastroenterol Hepatol (N Y). 2020 Sep;16(9):449-457.
2
Declining Rates of Surgery for Inflammatory Bowel Disease in the Era of Biologic Therapy.生物治疗时代炎症性肠病手术率下降。
J Gastrointest Surg. 2021 Jan;25(1):211-219. doi: 10.1007/s11605-020-04832-y. Epub 2020 Nov 2.
3
Analysis of Healthcare Resource Utilization and Costs after the Initiation of Biologic Treatment in Patients with Ulcerative Colitis and Crohn's Disease.溃疡性结肠炎和克罗恩病患者开始生物治疗后的医疗资源利用及成本分析。
J Health Econ Outcomes Res. 2018 Sep 1;6(1):96-112. doi: 10.36469/9791. eCollection 2018.
4
Cost-effectiveness Evaluation of Laparoscopic Versus Robotic Minimally Invasive Colectomy.腹腔镜与机器人微创结直肠切除术的成本效果评价。
Ann Surg. 2020 Aug;272(2):334-341. doi: 10.1097/SLA.0000000000003196.
5
Surgical Prevention of Anastomotic Recurrence by Excluding Mesentery in Crohn's Disease: The SuPREMe-CD Study - A Randomized Clinical Trial.手术排除克罗恩病肠系膜预防吻合口复发:SuPREMe-CD 研究——一项随机临床试验。
Ann Surg. 2020 Aug;272(2):210-217. doi: 10.1097/SLA.0000000000003821.
6
Assessing the efficacy of TNF-alpha inhibitors in preventing emergency and emergent colectomies.评估肿瘤坏死因子-α抑制剂在预防急诊和紧急结肠切除术方面的疗效。
JGH Open. 2019 Aug 2;4(2):140-144. doi: 10.1002/jgh3.12229. eCollection 2020 Apr.
7
Venous thromboembolism in inflammatory bowel disease.炎症性肠病中的静脉血栓栓塞症。
World J Gastroenterol. 2020 Mar 28;26(12):1231-1241. doi: 10.3748/wjg.v26.i12.1231.
8
Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based Analysis.生物制剂时代炎症性肠病的直接成本和医疗保健利用的纵向趋势:来自加拿大基于人群的分析结果。
Am J Gastroenterol. 2020 Jan;115(1):128-137. doi: 10.14309/ajg.0000000000000503.
9
Decreasing Colectomy Rates in Ulcerative Colitis in the Past Decade: Improved Disease Control?过去十年溃疡性结肠炎结肠切除术率降低:疾病控制改善?
J Gastrointest Surg. 2020 Feb;24(2):270-277. doi: 10.1007/s11605-019-04474-9. Epub 2019 Dec 3.
10
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.195 个国家和地区 1990-2017 年炎症性肠病的全球、区域和国家负担:2017 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2020 Jan;5(1):17-30. doi: 10.1016/S2468-1253(19)30333-4. Epub 2019 Oct 21.

生物制剂时代后炎症性肠病住院治疗的作用

Role of hospitalization for inflammatory bowel disease in the post-biologic era.

作者信息

Soriano Celine R, Powell Charleston R, Chiorean Michael V, Simianu Vlad V

机构信息

Department of Surgery, Virginia Mason Franciscan Health, Seattle, WA 98101, United States.

Department of Internal Medicine, Madigan Army Medical Center, Tacoma, WA 98431, United States.

出版信息

World J Clin Cases. 2021 Sep 16;9(26):7632-7642. doi: 10.12998/wjcc.v9.i26.7632.

DOI:10.12998/wjcc.v9.i26.7632
PMID:34621815
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8462259/
Abstract

Treatment for inflammatory bowel disease (IBD) often requires specialized care. While much of IBD care has shifted to the outpatient setting, hospitalizations remain a major site of healthcare utilization and a sizable proportion of patients with inflammatory bowel disease require hospitalization or surgery during their lifetime. In this review, we approach IBD care from the population-level with a specific focus on hospitalization for IBD, including the shifts from inpatient to outpatient care, the balance of emergency and elective hospitalizations, regionalization of specialty IBD care, and contribution of surgery and endoscopy to hospitalized care.

摘要

炎症性肠病(IBD)的治疗通常需要专科护理。虽然IBD护理的大部分工作已转移到门诊环境,但住院治疗仍然是医疗保健利用的主要场所,相当一部分炎症性肠病患者在其一生中需要住院或手术治疗。在本综述中,我们从人群层面探讨IBD护理,特别关注IBD的住院治疗,包括从住院治疗向门诊治疗的转变、急诊和择期住院治疗的平衡、IBD专科护理的区域化,以及手术和内镜检查对住院护理的贡献。